References

The Parkinson's-Reversing Breakthrough

Cure for Parkinson Disease

Get Instant Access

Ariano MA and Sibley DR (1994). Dopamine receptor distribution in the CNS: elucidation using anti-peptide antisera directed against Dia and D3 subtypes. Brain Res 649, 95-110.

Ariano MA, Wang J, Noblett KL, Larson ER, and Sibley DR (1997). Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res 752, 26-34.

Armstrong D and Strange PG (2001). Dopamine D2 receptor dimer formation: evidence from ligand binding. J Biol Chem 276, 22 621-9.

Baertschi AJ, Audigier Y, Lledo P-M, Israel J-M, Bockaert J, and Vincent J-D (1992). Dialysis of lactotropes with antisense oligonucleotides assigns guanine nucleotide binding protein subtypes to their channel effectors. Mol Endocrinol 6, 2257-65.

Bergson C, Mrzljak L, Lidow MS, Goldman-Rakic PS, and Levenson R (1995). Characterization of subtype-specific antibodies to the human D5 dopamine receptor: studies in primate brain and transfected mammalian cells. Proc Natl Acad Sci USA 92, 3468-72.

Boulay D, Depoortere R, Oblin A, Sanger DJ, Schoemacher H, and Perrault G (2000). Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice. Eur J Pharmacol 391, 63-73.

Boundy VA, Luedtke RR, Artymyshyn RP, Filtz TM, and Molinoff PB (1993). Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Mol Pharmacol 43, 666-76.

Boundy VA, Luedtke RR, Gallitano AL, Smith JE, Filtz TM, Kallen RG, and Molinoff PB (1993). Expression and characterization of the rat D3 dopamine receptor: pharmacological properties and development of antibodies. J Pharmacol Exp Ther 264, 1002-11.

Bouthenet M-L, Souil E, Martres MP, Sokofoff P, Giros B, and Schwartz J-C (1991). Localisation of dopamine D3 receptor mRNA in the rat brain using in situ hybridization hystochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564, 203-19.

Bowery BJ, Razzaque Z, Emms F, Patel S, Freedman S, Bristow L et al. (1996). Antagonism of the effects of (+)-PD 128907 on midbrain dopamine neurones in rat brain slices by a selective D2 receptor antagonist L-714,626. Br J Pharmacol 119, 1491-7.

Bunzow JR, Van Tol HHM, Grandy DK, Albert P, Salon J, Christie M et al. (1988). Cloning and expression of a rat D2 dopamine receptor. Nature 336, 783-7.

Castellano MA, Liu L-X, Monsma FJ, Sibley DR, Kapatos G, and Chiodo LA (1993). Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells. Mol Pharmacol 44, 649-56.

Castro SW and Strange PG (1993). Coupling of D2 and D3 dopamine receptors to G-proteins. FEBS Lett315, 223-6.

Chio CL, Hess GF, Graham RS, and Huff RM (1990). A second molecular form of D2 dopamine receptor in rat brain and bovine caudate nucleus. Nature 343, 266-9.

Chio CL, Drong RF, Riley DT, Gill GS, Slightom JL, and Huff RM (1994). D4 receptor-mediated signaling events determined in transfeceted chinese hamster ovary cells. JBiol Chem 269, 11 813-19.

Chio CL, Lajiness ME, and Huff RM (1994). Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. Mol Pharmacol 45, 51-60.

Clapham DE and Neer EJ (1993). New roles for G-protein Py-dimers in transmembrane signalling. Nature 365, 403-6.

Coldwell MC, Boyfield I, Brown AM, Stemp G, and Middlemiss DN (1999). Pharmacological characterization of extracellular acidification rate responses in human D2(long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 127, 1135-44.

Cordeaux Y, Nickolls SA, Flood LA, Graber SG, and Strange PG (2001). Agonist regulation of D2 dopamine receptor/G protein interaction: evidence for agonist selection of G protein subtype. J Biol Chem 276 28 667-75.

Crocq MA, Mant R, Asherson J, Williams J, Hode Y, Mayerova A et al. (1992). Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 29, 858-60.

Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A et al. (1989). The dopamine D2 receptor: Two molecular forms generated by alternative splicing. EMBO J 8, 4025-34.

Dearry A, Gringrich JA, Falardeau P, Fremeau RTJr, Bates MD, and Caron MG (1990). Molecular cloning and expression of the gene for a human D1 dopamine receptor. Biochem 29, 2335-42.

Defagot MC, Malchiodi EL, Villar MJ, and Antonelli MC (1997). Distribution of D4 dopamine receptor in rat brain with sequence-specific antibodies. Brain Res Mol Brain Res 45, 1-12.

Demchyshyn LL, Sugamori KS, Lee FJS, Hamadanizadeh SA, and Niznik HB (1995). The dopamine D1D receptor. Cloning and characterization of three pharmacologically distinct D1-like receptor from Gallus domesticus J Biol Chem 270, 4005-12.

Di Chiara G, Morelli M, Aquas E, and Carboni E (1992). Funtions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug action. Arzneimittelforschung42, 231-7.

Dulawa SC, Grandy DK, Low MJ, Paupus MP, and Geyer MA (1999). Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci 19, 9550-6.

Einhorn LC, Gregerson KA, and Oxford GS (1991). D2 dopamine receptor activation of potassium channels in identified rat lactotrophs: whole-cell and single-channel recording. J Neurosci 11, 3727-37.

Faure M, Voyno-Yasenetskaya TA, and Bourne HR (1994). cAMP and ßy subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells J Biol Chem 269, 7851-4.

Felder CC, Albrecht FE, Campbell T, Eisner GM, and Jose PA (1993). cAMP-dependent, G protein-linked inhibition of Na+/H+ exchange in renal brush border by Di dopamine agonists. Am JPhysiol 264, F1032-7.

Felder CC, Williams HL, and Axelrod J (1991). A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP-mediated arachidonic acid release. Proc Natl Acad Sci USA 88, 6477-80.

Fishburn CS, Carmon S, and Fuchs S (1995). Molecular cloning and characterisation of the gene encoding the murine D4 dopamine receptor. FEBSLett 361, 215-19.

Fishburn CS, David C, Carmon S, Wein C, and Fuchs S (1994). In vitro translation of D2 dopamine receptors and their chimaeras: analysis of subtype-specific antibodies. Biochem Biophys Res Commun 205, 1460-6.

Florio T, Pan M-G, Newman B, Hershberger RE, Civelli O, and Stork PJS (1992). Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity. J Biol Chem 267, 24 169-72.

Frail DE, Manelli AM, Witte DG, Lin CW, Steffey ME, and MacKenzie RG (1993). Cloning and characterization of a truncated dopamine D1 receptor from goldfish retina: stimulation of cyclic AMP production and calcium mobilization. Mol Pharmacol 44, 1113-18.

Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR etal. (1994). Expression and pharmacological characterization of the human D3 dopamine receptor. J Pharmacol Exp Ther 268, 417-26.

Fryxell KJ (1994). The evolution of the dopamine receptor family. In (ed. HB Niznik), Dopamine Receptor and Transporters Dekker, New York, pp. 237-60.

Gandelman K-Y, Harmon S, Todd RD, and O'Malley KL (1992). Analysis of the structure and expression ofthe human dopamine D2a receptor gene. J Neurochem 56, 1024-9.

Ganz MB, Pachter JA, and Barber DL (1990). Multiple receptor coupled to adenylate cyclase regulate Na-H exchange independent of cAMP. J Biol Chem 265, 8989-92.

Gazi L, Bobirnac I, Danzeisen M, Schupbach E, Bruinvels AT, Geisse S et al. (1998). The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4 4 receptor. Br J Pharmacol 124, 889-96.

Gazi L, Nickolls SA, and Strange PG (2001). Human dopamine D2L(iong) receptor coupling to Gai2 and Gao G proteins in Sf9 insect cells. Abstract at British Pharmacological Society Dublin Meeting P106.

Gazi L, Schoeffter P, Nunn C, Croskery K, Hoyer D, and Feuerbach D (2000). Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor. Naunyn Schmiedeberg's Arch Pharmacol 361, 555-64.

Gelernter J, Kennedy JL, Van Tol HHM, Civelli O, and Kidd KK (1992). The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. Genomics 13, 208-10.

Gharhremani MH, Cheng PH, Lembo PMC, and Albert PR (1999). Distinct roles for G alpha(i)2, Galpha(i)3, and G beta gamma in modulation of forskolin- or G(s)-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors. J Biol Chem 274, 9238-45.

Giros B, Martres MP, Pilon C, Sokofoff P, and Schwartz J-C (1991). Shorter variant of the dopamine D3 receptor produced through various patterns of alternative splicing. Biochem Biophys Res Commun 176, 1584-92.

Giros B, Sokoloff P, Martres M-P, Riou J-F, Emorine LJ, and Schwartz J-C (1989). Alternative splicing directs the expression of two D2 dopamine receptor isoforms. Nature 342, 923-6.

Grandy DK, Litt M, Allen L, Bunzow JR, Machioni M, Makam H etal. (1989). The human dopamine D2 receptor is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet 45, 778-85.

Grandy DK, Machioni MA, Makam H, Stofko RE, Alfano M, Frothingham L etal. (1989). Cloning of the cDNA and a gene for a human D2 dopamine receptor. Proc Natl Acad Sci USA 86, 9762-6.

Grandy DK, Zhang Y, Bouvier C, Zhou Q-Y, Johnson RA, Allen L etal. (1991). Multiple human D5 receptor genes: a functional receptor and two pseudogenes. Proc Natl Acad Sci USA 88, 9175-9.

Grandy DK, Zhou Q-Y, Allen L, Litt R, Magenis RE, Civelli O etal. (1990). A human dopamine D1 receptor gene is located on chromosome 5 at q35.1 and identifies an ExoRI RFLP. Am J Hum Genet 47, 828-34.

Hall DA and Strange PG (1999). Comparison of the ability of dopamine receptor agonists to inhibit forskolin-stimulated adenosine 3'5'-cyclic monophosphate (cAMP) accumulation via D2L (long isoform) and D3 receptor expressed in Chinese hamster ovary (CHO) cells. Biochem Pharmacol 58, 285-9.

Hartman DS and Civelli O (1997). Dopamine receptor diversity: molecular and pharmacological perspectives. In (ed. E Jucker) Progress in Drug Research, Vol. 4, Basel: Birkhäuser, 173-94.

Hawes BE, Luttrel LM, Exum ST, and Lefkowitz RJ (1994). Inhibition of G protein-coupled receptor signaling by expression of cytoplasmic domains of the receptor. J Biol Chem 269, 15 776-85.

Hayes G, Biden TJ, Selbie LA, and Shine J (1992). Structural subtypes of the dopamine D2 receptor are functionally distinct: expression of the cloned D2a and D2b subtypes in a heterologous subtypes. Mol Endocrinol 6, 920-6.

Kanterman RY, Mahan LC, Briley EM, Monsma FJ, Sibley DR, Axelrod J etal. (1991). Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. Mol Pharmacol 39, 364-9.

Karpa KD, Lin R, Kabbani N, and Levenson R (2000). The dopamine D3 receptor interacts with itself and the truncated D3 splice variant D3nf: D3-D3nf interaction causes mislocalization of D3 receptors. Mol Pharmacol 58, 677-83.

Kazmi MA, Snyder LA, Cypess AM, Graber SG, and Sakmar TP (2000). Selective reconstitution of human D4 dopamine receptor variants with Gi alpha subtypes. Biochemistry 39, 3734-44.

Kebabian JW and Calne DB (1979). Multiple receptors for dopamine. Nature 277, 93-6.

Khan ZU, Gutierrez A, Martin R, Penafiel A, Rivera A, and De La Calle A (1998). Differential regional and cellular distribution of dopamine D2-like receptor: immunocytochemical study of subtype-specific antibodies in rat and human. J Comp Neurol 402, 353-71.

Khan ZU, Gutierrez A, Martin R, Penafiel A, Rivera A, and De La Calle A (2000). Dopamine D5 receptor of rat and human brain. Neuroscience 100, 689-99.

Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, and Lefkowitz RJ (1988). Chimeric a2-, ß2-adrenergic receptor: delineation of domains involved in effector coupling and ligand binding specificity. Science 240, 1310-16.

Konig B and Gratzel M (1994). Site of dopamine D1 receptor binding to Gs protein mapped with synthetic peptides. Biochim Biophys Acta 1223, 261-6.

Kozell LB, Machida CA, Neve RL, and Neve KA (1994). Chimeric Di /D2 dopamine receptors. Distinct determinant of selective efficacy, potency, and signal transduction. J Biol Chem 269, 30 299-306.

Kramer MS, Last B, Getson A, and Reines S (1997). The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic in patients with schizophrenia. Arch Gen Psychiatry 54, 567-72.

Laitinen JT (1993). Dopamine stimulates K+ efflux in the chick retina via D1 receptors independently of adenylyl cyclase activation. J Neurochem 61, 1461-9.

Lajiness ME, Chio CL, and Huff RM (1993). D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: relationship to dopamine stimulation of tyrosine phosphorylation. J Pharmacol Exp Ther 267, 1573-81.

Lanau F, Brockhaus M, Pink JR, Franchet C, Wildt-Perinic D, Goepfert C etal. (1997). Development and characterization of antibodies against the N terminus of the human dopamine D4 receptor. J Neurochem 69, 2169-78.

Laurier LG, O'Dowd BF, and George SR (1994). Heterogeneous tissue-specific transcription of dopamine receptor subtype messenger RNA in rat brain. Mol Brain Res 25, 344-50.

Le W-D and Jankovic J (2001). Are dopamine receptor agonists neuroprotective in Parkinson's disease? Drugs and Aging 18(6), 389-96.

Le Corniat M, Hillion J, Martres MP, Giros B, Pilon C, Schwartz J-C etal. (1991). Chromosomal localisation of the human D3 dopamine receptor gene. Hum Genet 87, 618-20.

Lee SP, O'Dowd BF, Ng GYK, Varghese G, Akil H, Mansour A etal. (2000). Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in cell. Mol Pharmacol 58, 120-8.

Lichter JB, Barr CL, Kennedy JL, Van Tol HHM, Kidd KK, and Livak KJ (1993). A hyper-variable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet2, 757-63.

Liu F, Wan Q, Pristupa ZB, Yu X-M, Wang YT, and Niznik HB (2000). Direct protein-protein coupling enables cross-talk between dopamine D5 and gamma-aminobutyric acid A receptors. Nature 403, 274-80.

Liu K, Bergson C, Levenson R, and Schmauss C (1994). On the origin of mRNA encoding the truncated dopamine D3-type receptor D3nf and detection of D3nf-like immunoreactivity in human brain. J Biol Chem 269, 29 220-6.

Liu YF, Civelli O, Grandy DK, and Albert PR (1992). Differential sensitivity of the short and long human dopamine D2 receptor subtypes to protein kinase C. J Neurochem 59, 2311-17.

Liu YF, Civelli O, Zhou Q-Y, and Albert PR (1992). Cholera toxin-sensitive 3'5'-cyclic adenosine monophosphate and calcium signals of the human dopamine D1 receptor: selective potentiation by proteine kinase A. Mol Endocrinol 6, 1815-24.

Liu YF, Jakobs KH, Rasenick MM, and Albert PR (1994). G rotein specificity in receptor-effector coupling. Analysis ofthe roles of Go and Gi2 in GH4C1 pituitary cells. J Biol Chem 269, 13 880-6.

Livak KJ, Rogers J, and Lichter JB (1995). Variability of dopamine D4 receptor (DRD4) gene sequence within and among nonhuman primate species. Proc Natl Acad Sci USA 92, 427-31.

Lledo P-M, Homburger V, Bockaert J, and Vincent J-D (1992). Differential G protein-mediated coupling ofD2 dopamine receptors to K+ and Ca2+ currents in rat pituitary cells. Neuron 8, 455-63.

Luedtke RR, Griffin SA, Conroy SS, Jin X, Pinto A, and Sesack SR (1999). Immunoblot and immunohis-tochemical comparison of murine monoclonal antibodies specific for the rat Dia and D ¡b dopamine receptor subtypes. JNeuroimmunol 101, 170-87.

Lustig KD, Conklin BR, Herzmark P, Taussig R, and Bourne HR (1993). Type II adenylyl cyclase integrates coincident signals from Gs, Gi, and Gq. J Biol Chem 268, 13 900-05.

Luttrel LM, Ostrowsky J, Cotecchia S, Kendall H, and Lefkowitz RJ (1993). Antagonism of catecholamine receptor signaling by expression of cytoplasmic domain of the receptor. Science 259, 1453-7.

Machida CA, Searles RP, Nipper V, Brown JA, Kozel LB, and Neve KA (1992). Molecular cloning and expression of the rhesus macaque D1 dopamine receptor gene. Mol Pharmacol 41, 652-9.

MacKenzie RG, Vanleeuwen D, Pugsley TA, Shih Y-H, Demattos S, Tang L etal. (1994). Characterization of the human dopamine D3 receptor expressed in transfected cell lines. Eur J Pharmacol-Mol Pharmacol 266, 79-85.

MacKenzie RG, Vanleeuwen D, Pugsley TA, Shih Y-H, Demttos S, Tang L etal. (1994). Characterization of the human dopamine D3 receptor expressed in transfected cell lines. Eur J Pharmacol 266, 79-85.

MalekD, Munch G, and Palm D (1993). Two sites in the third inner loop of the dopamine D2 receptor are involved in functional G protein-mediated coupling to adenylate cyclase. FEBS Lett 325, 215-19.

Martens GJM, Molhuizen HOF, Groneveld D, and Roubos EW (1991). Cloning and sequence analysis of brain cDNA encoding a Xenopus D2 dopamine receptor. FEBSLett 281, 85-9.

Matsumoto M, Hidaka K, Tada S, Tasaki Y, and Yamaguchi T (1995). Polymorphic tandem repeats in dopamine D4 receptor are spread over primate species. Biochem Biophys Res Commun 207, 467-75.

McAllister G, Knowles MR, Patel S, Marwood R, Emms F, SeabrookGR etal. (1993). Characterisation of a chimeric hD3 /D2 dopamine receptor expressed in CHO cells. FEBS Lett 324, 81-6.

McAllister G, Knowles MR, Ward-Booth SM, Sinclair HA, Patel S, Marwood R etal. (1995). Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells. J Receptor Signal Trans Res 15,267-81.

Mei YA, Griffon N, Buquet C, Martres MP, Vaudry H, Schwartz J-C et al. (1995). Activation of dopamine D4 receptor inhibits an L-type calcium current in cerebellar granule cells. Neuroscience 68, 107-16.

Memo M, Pizzi M, Belloni M, BenareseM, and Spano PF (1992). Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. JNeurochem 59, 1829-35.

Miller JC, Wang Y, and Filer D (1990). Identification by sequence analysis of a second rat brain cDNA encoding the dopamine (D2) receptor. Biochem Biophys Res Commun 166, 109-12.

Minowa MT, Minowa T, Monsma FJ, Sibley DR, and Mouradian MM (1992). Characterization of the 5' flanking region of the human D1a dopamine receptor gene. Proc Natl Acad Sci USA 89, 3045-9.

Missale C, Nash R, Robinson SW, Jaber M, andCaronMG (1998). Dopamine receptors: from structure to function. Physiolgical Rev 78, 189-224.

Monsma FJ, McVittie LD, Gerfen CR, Mahan LC, and Sibley DR (1989). Multiple dopamine D2 receptors produced by alternative RNA splicing. Nature 342, 926-9.

Monsma FJJr, Shen Y, Gerfen CR, Mahan LC, and Sibley DR (1990). Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci USA 87, 6723-7.

Montmayeur JP and Borelli E (1991). Transcription mediated by cAMP-responsive promoter element is reduced upon activation of dopamine D2 receptors. Proc Natl Acad Sci USA 88, 3135-9.

Montmayeur JP, Bausero P, Amlaiky N, Moroteaux L, Hen R, and Borelli E (1991). Differential expression of the mouse D2 dopamine receptor isoforms. FEBS Lett 278, 239-43.

Montmayeur JP, Guiramand J, and Borelli E (1993). Preferential coupling between dopamine D2 receptors and G proteins. Mol Endocrinol 7, 161-70.

MoraFerrer C, Yazulla S, and Studholme KM (1997). A novel D1-dopamine receptor antibody labels D1-receptors in lower and higher vertebrate retinas. Invest Ophth Vis Sci 38, 217-17.

Neer EJ (1995). Heterotrimeric G proteins: organisers of transmembrane signals. Cell 80, 249-57.

Neve KA and Neve RL (1997). The Dopamine Receptors, Humana Press, Totowa, NJ.

Neve KA, Cox BA, Henningsen RA, Spanoyannis A, and Neve RL (1991). Pivotal role of aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol Pharmacol 39, 733-9.

Neve KA, Kozlowski MR, and Rosser MP (1992). Dopamine D2 receptor stimulation of Na+/H+ exchange assessed by quantification of extracellular acidification. J Biol Chem 267, 25 748-53.

Neve KA, Neve RL, Fidel S, Janowsky A, and Higgins GA (1991). Increased abundance of alternatively spliced forms of D-2 receptor mRNA after denervation. Proc Natl Acad Sci USA 88,2802-06.

Nickolls SA and Strange PG (2001). Preferential coupling of D2s dopamine receptors to alphao G proteins over alphai2 G proteins. Br J Pharmacol 133, p. 129.

Nimchinsky EA, Hof PR, Janssen WGM, Morrison JH, and Schmauss C (1997). Expression of dopamine receptor dimers and tetramers in brain and in transfected cells. J Biol Chem 272, 29229-37.

Nussinovitch I and Kleinhaus AL (1992). Dopamine inhibits voltage-activated calcium channel currents in rat pars intermedia pituitary cells. Brain Res 574, 49-55.

O'Malley KL, Mack KJ, Gandelman K-Y, and Todd RD (1990). Organisation and expression of the rat D2A receptor gene: identification of alternative transcripts and a variant donor splice site. Biochemistry 29, 1367-71.

O'Malley KL, Harmon S, Tang L, and Todd RD (1992). The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. New Biologist 4, 137-46.

ParkB-H, FishburnCS, Carmon S, Accili D, and Fuchs S (1995). Structural organization of the murine D3 dopamine receptor gene. J Neurochem 64, 482-6.

Patel S, Freedman S, Chapman KL, Emms F, Fletcher AE, Knowles M etal. (1997). Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther 283,636-47.

Pearce RKB (1996) Dopamine D1 receptor agonists and dopamine reuptake blockers: new treatment statagems fo Parkinson's disease. Exp Opin Ther Patents 6(10), 949-53.

Pedersen UB, Norby B, Jensen AA, Schiodt M, Hansen A, Suhr-Jessen P etal. (1994). Characteristics of stably expressed human Dia and Djb receptors: atypical behavior of the dopamine Djb receptor. Eur J Pharmacol 267, 85-93.

Petronis A, Van Tol HHM, Lichter JB, Livak KJ, and Kennedy JL (1993). The D4 dopamine receptor gene maps on 11p proximal to HRAS Genomics 18, 161-3.

Pilon C, Levesque D, Dimitriadou V, Griffon N, Martres MP, Schwartz J-C etal. (1994). Functional coupling of the human dopamine D3 receptor in a transfected NG 108-15 neuroblastoma-glioma hybrid cell line. Eur JPharmacol-Mol Pharmacol 268, 129-39.

Pilon C, Levesque D, Dimitriadou V, Griffon N, Martres MP, Schwartz J-C etal. (1994). Functional coupling of the human dopamine D3 receptor in a transfected NG108-15 neuroblastoma-glioma hybrid cell line. Eur JPharmacol 268, 129-39.

Piomelli D, Pilon C, Giros B, Sokoloff P, Martres M-P, and Schwartz J-C (1991). Dopamine activation of the arachidonic acid cascade as a basis for D1 /D2 synergism. Nature 353, 164-367.

Plug MJ, Dijk J, Maassen A, and Moller W (1992). An anti-peptide antibody that recognizes the dopamine D2 receptor from bovine striatum. Eur J Biochem 206, 123-30.

Pollok NJ, Manelli AM, Hutchins CW, Steffey ME, MacKenzie RG, and Frail DE (1992). Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. J Biol Chem 267, 17 780-6.

Polymeropoulos MH, Xiao H, and Merril CR (1991). The human D5 dopamine receptor (DRD5) maps on chromosome 4. Genomics 11, 777-8.

Potenza MN, Graminski GF, Schmauss C, and Lerner MR (1994). Functional expression and characterization of human D2 and D3 dopamine receptors. J Neurosci 14, 1463-76.

Ralph RJ, Varty GB, Kelly MA, Wang YM, Caron MG, Rubinstein M etal. (1999). The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci 19, 4627-33.

Rao DD, McKelvy KJ, Gandelman K-Y, and MacKenzie RG (1990). Two forms of the rat D2 dopamine receptor as revealed by the polymerase chain reaction. FEBS Lett 263, 18-22.

Robinson SW and Caron MG (1996). Chimeric D2/D3 dopamine receptor efficiently inhibit adenylyl cyclase in HEK293 cells. J Neurochem 67, 212-19.

Robinson SW, Jarvie KR, and Caron MG. (1994). High affinity agonist binding to the dopamine D3 receptor: chimeric receptor delineate a role for intracellular domain. Mol Pharmacol 46, 352-6.

Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, and Patel YC (2000). Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288, 154-8.

Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G etal. (1997). Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and metamphetamine. Cell 90,991-1001.

Schmauss C, Haroutunian V, Davis KL, and Davidson M (1993). Selective loss of dopamine D3-type receptor mRNA expression in partial and motor cortices of patients with chronic schizophrenia. Proc Natl Acad Sci USA 19, 8942-6.

Seabrook GR, Kemp JA, Freedman SB Patel S, Sinclair HA, and McAllister G (1994). Functional expression of human D3 dopamine receptors in differentiated neuroblastoma x glioma NG108-15 cells. Br J Pharmacol 111, 391-3.

Seabrook GR, Knowles MR, Brown N, Myers J, Sinclair H, Patel S etal. (1994). Pharmacology of high-threshold calcium currents in GH4Cj pituitary cells and their regulation by activation of dopamine D2 and D4 dopamine receptors. Br J Pharmacol 112, 728-34.

Seabrook GR, Patel S, MarwoodR, EmmsF, Knowles MR Freedman SB etal. (1992). Stable expression of human D3 dopamine receptors in GH4Ci pituitary cells. FEBS Lett 312, 123-6.

Selbie LA, Hayes G, and Shine J (1989). The major dopamine D2 receptor: molecular analysis of the human D2A subtype. DNA 8, 683-9.

Senogles I (1994). The D2 dopamine receptor mediates inhibition of growth inGH4ZR7 cells: involvement of protein kinase-Ce. Endocrinology 134, 783-9.

Senogles SE (1994). The D2 dopamine receptor isoforms signal through distinct Gia proteins to inhibit adenylyl cyclase. A study with site-directed mutant Gia proteins. J Biol Chem 269, 23 120-7.

Snyder LA, Roberts JL, and Sealfon SC (1991). Distribution of dopamine receptor mRNA splice variants in the rat by solution hybridisation/protection assay. Neurosci Lett 122, 37-40.

Sokofoff P, Giros B, Martres MP, Bouthenet ML, and Schwartz J-C (1990). Molecular cloning and characterization of a novel dopamine receptor (D3) as target for neuroleptics. Nature 347, 146-51.

Spurlock G, Williams J, McGuffin P, Aschauer HN, Lenzinger E, Fuchs K et al. (1998). European multicentre association study of schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms. Am J Med Genet 81, 24-8.

Stemp G, Ashmeade T, Branch CL, Hadley MS, Hunter AJ, Johnson DJ et al. (2000). Design and synthesis oftrans-N-[4-[2-(6-cyano-1,2,3,4-tetraisoquinolin-2-yl)ethyl]-4-quinolinec (SB-277011): a potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in rat. J Med Chem 43, 1878-85.

Strader CD, Dixon RAF, Cheung AH, Candelore MR, Blake AD, and Sigal IL (1987). Mutations that uncouple the ß-adrenergic receptor from Gs and increase agnonist affinity. J Biol Chem 262, 16 439-43.

Strange PG (2001). Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol Rev 53, 1-15.

Sugamori KS, Demchyshyn LL, Chung M, and Niznik HB (1994). D1a, D1b, and D1c dopamine receptor from Xenepus laevis. Proc Natl Acad Sci USA 91,10 536-40.

Sunahara RK, Guan HC, O'Dowd BF, Seeman P, Laurier LG, Ng G etal. (1991). Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350, 614-19.

Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL etal. (1990). Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature 347, 80-3.

Tan E-K and Jankovic J (2001). Choosing dopamine agonists in Parkinson's disease. Clin Neurophar-macol 24(5), 247-53.

Tang L, Todd RD, and O'Malley KL (1994) Dopamine D2 and D3 receptors inhibit dopamine release. JPharmacol Exp Ther 270, 475-9.

Tang L, Todd RD, Heller A, and O'Malley KL (1994). Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J Pharmacol Exp Ther 268, 495-502.

Tiberi M and Caron MG (1994). High agonist-independant activity is a distinguishing feature of the dopamine D1b receptor subtype. J Biol Chem 269, 27 925-31.

Tiberi M, Jarvie KR, Silvia C, Faladeau P, Gringrich JA, Godinot N etal. (1991). Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D 1a receptor. Proc Natl Acad Sci USA 88, 7491-5.

Todd RD and O'Malley KL (2001). The dopamine receptor DRD4 gene: are duplications distracting? TiPS 22, 55-6.

Truffinet P, Tamminga CA, Fabre LF, Meltzer HY, Riviere M-E, and Papillon-Downy C (1999). Placebo-controlled study of the D4/5-HT2A agonist Fanaserin in the treatment of schizophrenia. Am J Psychiatry 156, 419-25.

Undie AS and Friedman E (1994). Stimulation of dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 253, 987-92.

Usiello A, Baik J-H, Rouge-Pont F, Picetti R, Dierich A, LeMeur M etal. (2000). Distinct functions of the two isoforms of dopamine D2 receptors. Nature 408, 199-202.

Vallar L, MucaC, Magni M, Albert P, Bunzow J etal. (1990). Differential coupling of dopaminergic D2 receptors expressed in different cell types. Stimulation of phosphsinositol 4,5-bisphosphate hydrolysis in Ltk- fibroblasts, hyperpolazisation, and cytosolic-free Ca2+ concentration decrease in GH4C1 cells. J Biol Chem 265, 10 320-6.

Van Tol HHM, Bunzow JR, Guan H-C, Sunahara RK, Seeman P, Niznik HB, and Civelli O (1991). Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350, 610-4.

VossT, Wallner E, Czernilofsky AP, and Freissmuth M (1993). Amphipathic a-helical structure does not predict the ability of receptor-derived synthetic peptides to interact with guanine nucleotide-binding regulatory proteins. J Biol Chem 268, 4637-42.

Wilke RA, Hsu S-F, and Meyer BJ (1998). Dopamine D4 receptor mediated inhibition of potassium current in Neurophysial Nerve Terminals. J Pharmacol Exp Ther 284, 542-8.

Zawarynski P, Tallerico T, Seeman P, Lee SP, O'Dowd BF, and George SR (1998). Dopamine D2 receptor dimers in human and rat brain. FEBS Lett 456, 63-7.

Zawilska JB and Nowak JZ (1997). Dopamine D4-like receptors in vertebrate retina: does the retina offer a model for the D4-receptor analysis? Pol J Pharmacol 49, 201-11.

Zhou Q-Y, Grandy DK, Thambi L, Kushner JA, Van Tol HHM, Cone R et al. (1990). Cloning and expression of human and rat D1 dopamine receptors. Nature 347, 76-9.

Zhou Q-Y, Li C, and Civelli O (1992). Characterization of gene organisation and promoter region of the rat dopamine D1 receptor gene. J Neurochem 59, 1875-83.

Was this article helpful?

0 0

Post a comment